Skyhawk news

Browse:

Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression

July 8, 2019
Bill Haney’s Skyhawk spears another marquee alliance for its work drugging RNA in Takeda neuro pact
Com­ing af­ter its Shire buy­out, Take­da has al­lied with Sky­hawk to dis­cov­er new small mol­e­cules for un­spec­i­fied neu­ro­log­i­cal
Read
1 min read
January 7, 2019
Top 20 Life Science Startups to Watch in 2019
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America
Read
1 min read
January 4, 2019
Biogen looks to expand neuro pipeline via C4, Skyhawk deals
A pair of deals announced Friday leaves Biogen Inc. (NASDAQ:BIIB) poised to expand the druggable space of its neurology pipeline. Biogen...
Read
1 min read
January 4, 2027
Joining forces with Skyhawk, C4 Therapeutics, Biogen buys more shots on goal on SMA, Alzheimer’s
In twin deals an­nounced on Fri­day, Bio­gen $BI­IB is ty­ing up with Sky­hawk Ther­a­peu­tics
Read
2 min read
June 26, 2026
Skyhawk Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing
Skyhawk and Celgene enter into a five-year strategic collaboration.
Read
2 min read